Global Liposomes Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Liposomes Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Liposomes Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes Drug Delivery Market Size Growth Rate by Type
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposomes Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposomes Drug Delivery Revenue 2016-2027
2.1.2 Global Liposomes Drug Delivery Sales 2016-2027
2.2 Liposomes Drug Delivery Market Size by Region: 2021 Versus 2027
2.3 Liposomes Drug Delivery Sales by Region (2016-2027)
2.3.1 Global Liposomes Drug Delivery Sales by Region: 2016-2021
2.3.2 Global Liposomes Drug Delivery Sales Forecast by Region (2022-2027)
2.3.3 Global Liposomes Drug Delivery Sales Market Share by Region (2016-2027)
2.4 Liposomes Drug Delivery Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Liposomes Drug Delivery Revenue by Region: 2016-2021
2.4.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027)
2.4.3 Global Liposomes Drug Delivery Revenue Market Share by Region (2016-2027)
3 Global Liposomes Drug Delivery by Manufacturers
3.1 Global Top Liposomes Drug Delivery Manufacturers by Sales
3.1.1 Global Liposomes Drug Delivery Sales by Manufacturer (2016-2021)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Liposomes Drug Delivery Manufacturers by Revenue
3.2.1 Global Liposomes Drug Delivery Revenue by Manufacturer (2016-2021)
3.2.2 Global Liposomes Drug Delivery Revenue Share by Manufacturer (2016-2021)
3.3 Global Liposomes Drug Delivery Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Liposomes Drug Delivery Manufacturers Covered: Ranking by Revenue
3.4.2 Global Liposomes Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Liposomes Drug Delivery Manufacturing Base Distribution, Product Type
3.5.1 Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Liposomes Drug Delivery Product Type
3.5.3 Date of International Manufacturers Enter into Liposomes Drug Delivery Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson Corporation Information
4.1.2 Johnson & Johnson Description, Business Overview
4.1.3 Johnson & Johnson Liposomes Drug Delivery Products Offered
4.1.4 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Johnson & Johnson Liposomes Drug Delivery Revenue by Product
4.1.6 Johnson & Johnson Liposomes Drug Delivery Revenue by Application
4.1.7 Johnson & Johnson Liposomes Drug Delivery Revenue by Geographic Area
4.1.8 Johnson & Johnson Liposomes Drug Delivery Revenue by Sales Channel
4.1.9 Johnson & Johnson Recent Development
4.2 Gilead Sciences
4.2.1 Gilead Sciences Corporation Information
4.2.2 Gilead Sciences Description, Business Overview
4.2.3 Gilead Sciences Liposomes Drug Delivery Products Offered
4.2.4 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Gilead Sciences Liposomes Drug Delivery Revenue by Product
4.2.6 Gilead Sciences Liposomes Drug Delivery Revenue by Application
4.2.7 Gilead Sciences Liposomes Drug Delivery Revenue by Geographic Area
4.2.8 Gilead Sciences Liposomes Drug Delivery Revenue by Sales Channel
4.2.9 Gilead Sciences Recent Development
4.3 Pacira
4.3.1 Pacira Corporation Information
4.3.2 Pacira Description, Business Overview
4.3.3 Pacira Liposomes Drug Delivery Products Offered
4.3.4 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Pacira Liposomes Drug Delivery Revenue by Product
4.3.6 Pacira Liposomes Drug Delivery Revenue by Application
4.3.7 Pacira Liposomes Drug Delivery Revenue by Geographic Area
4.3.8 Pacira Liposomes Drug Delivery Revenue by Sales Channel
4.3.9 Pacira Recent Development
4.4 Sun Pharmaceutical
4.4.1 Sun Pharmaceutical Corporation Information
4.4.2 Sun Pharmaceutical Description, Business Overview
4.4.3 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
4.4.4 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Product
4.4.6 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Application
4.4.7 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Geographic Area
4.4.8 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Sales Channel
4.4.9 Sun Pharmaceutical Recent Development
4.5 Luye Pharma
4.5.1 Luye Pharma Corporation Information
4.5.2 Luye Pharma Description, Business Overview
4.5.3 Luye Pharma Liposomes Drug Delivery Products Offered
4.5.4 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Luye Pharma Liposomes Drug Delivery Revenue by Product
4.5.6 Luye Pharma Liposomes Drug Delivery Revenue by Application
4.5.7 Luye Pharma Liposomes Drug Delivery Revenue by Geographic Area
4.5.8 Luye Pharma Liposomes Drug Delivery Revenue by Sales Channel
4.5.9 Luye Pharma Recent Development
4.6 Sigma-Tau Group
4.6.1 Sigma-Tau Group Corporation Information
4.6.2 Sigma-Tau Group Description, Business Overview
4.6.3 Sigma-Tau Group Liposomes Drug Delivery Products Offered
4.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Sigma-Tau Group Liposomes Drug Delivery Revenue by Product
4.6.6 Sigma-Tau Group Liposomes Drug Delivery Revenue by Application
4.6.7 Sigma-Tau Group Liposomes Drug Delivery Revenue by Geographic Area
4.6.8 Sigma-Tau Group Recent Development
4.7 Fudan-Zhangjiang
4.7.1 Fudan-Zhangjiang Corporation Information
4.7.2 Fudan-Zhangjiang Description, Business Overview
4.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
4.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Product
4.7.6 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Application
4.7.7 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Geographic Area
4.7.8 Fudan-Zhangjiang Recent Development
4.8 Teva Pharmaceutical
4.8.1 Teva Pharmaceutical Corporation Information
4.8.2 Teva Pharmaceutical Description, Business Overview
4.8.3 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
4.8.4 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Product
4.8.6 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Application
4.8.7 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Geographic Area
4.8.8 Teva Pharmaceutical Recent Development
4.9 CSPC
4.9.1 CSPC Corporation Information
4.9.2 CSPC Description, Business Overview
4.9.3 CSPC Liposomes Drug Delivery Products Offered
4.9.4 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.9.5 CSPC Liposomes Drug Delivery Revenue by Product
4.9.6 CSPC Liposomes Drug Delivery Revenue by Application
4.9.7 CSPC Liposomes Drug Delivery Revenue by Geographic Area
4.9.8 CSPC Recent Development
4.10 Novartis
4.10.1 Novartis Corporation Information
4.10.2 Novartis Description, Business Overview
4.10.3 Novartis Liposomes Drug Delivery Products Offered
4.10.4 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Novartis Liposomes Drug Delivery Revenue by Product
4.10.6 Novartis Liposomes Drug Delivery Revenue by Application
4.10.7 Novartis Liposomes Drug Delivery Revenue by Geographic Area
4.10.8 Novartis Recent Development
4.11 Kingond Pharm
4.11.1 Kingond Pharm Corporation Information
4.11.2 Kingond Pharm Description, Business Overview
4.11.3 Kingond Pharm Liposomes Drug Delivery Products Offered
4.11.4 Kingond Pharm Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Kingond Pharm Liposomes Drug Delivery Revenue by Product
4.11.6 Kingond Pharm Liposomes Drug Delivery Revenue by Application
4.11.7 Kingond Pharm Liposomes Drug Delivery Revenue by Geographic Area
4.11.8 Kingond Pharm Recent Development
4.12 Spectrum Pharmaceuticals
4.12.1 Spectrum Pharmaceuticals Corporation Information
4.12.2 Spectrum Pharmaceuticals Description, Business Overview
4.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Products Offered
4.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue by Product
4.12.6 Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue by Application
4.12.7 Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue by Geographic Area
4.12.8 Spectrum Pharmaceuticals Recent Development
4.13 Shanghai New Asia
4.13.1 Shanghai New Asia Corporation Information
4.13.2 Shanghai New Asia Description, Business Overview
4.13.3 Shanghai New Asia Liposomes Drug Delivery Products Offered
4.13.4 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Shanghai New Asia Liposomes Drug Delivery Revenue by Product
4.13.6 Shanghai New Asia Liposomes Drug Delivery Revenue by Application
4.13.7 Shanghai New Asia Liposomes Drug Delivery Revenue by Geographic Area
4.13.8 Shanghai New Asia Recent Development
5 Breakdown Data by Type
5.1 Global Liposomes Drug Delivery Sales by Type (2016-2027)
5.1.1 Global Liposomes Drug Delivery Sales by Type (2016-2021)
5.1.2 Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027)
5.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2016-2027)
5.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2016-2027)
5.2.1 Global Liposomes Drug Delivery Revenue by Type (2016-2021)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2022-2027)
5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2016-2027)
5.3 Liposomes Drug Delivery Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Liposomes Drug Delivery Sales by Application (2016-2027)
6.1.1 Global Liposomes Drug Delivery Sales by Application (2016-2021)
6.1.2 Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027)
6.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2016-2027)
6.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2016-2027)
6.2.1 Global Liposomes Drug Delivery Revenue by Application (2016-2021)
6.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027)
6.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2016-2027)
6.3 Liposomes Drug Delivery Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Liposomes Drug Delivery Market Size YoY Growth 2016-2027
7.2 North America Liposomes Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposomes Drug Delivery Sales by Country (2016-2027)
7.2.2 North America Liposomes Drug Delivery Revenue by Country (2016-2027)
7.3 North America Liposomes Drug Delivery Sales by Type
7.4 North America Liposomes Drug Delivery Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Liposomes Drug Delivery Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Liposomes Drug Delivery Market Facts & Figures by Region
8.2.1 Asia-Pacific Liposomes Drug Delivery Sales by Region (2016-2027)
8.2.2 Asia-Pacific Liposomes Drug Delivery Revenue by Region (2016-2027)
8.3 Asia-Pacific Liposomes Drug Delivery Sales by Type
8.4 Asia-Pacific Liposomes Drug Delivery Sales by Application
9 Europe
9.1 Europe Liposomes Drug Delivery Market Size YoY Growth 2016-2027
9.2 Europe Liposomes Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposomes Drug Delivery Sales by Country (2016-2027)
9.2.2 Europe Liposomes Drug Delivery Revenue by Country (2016-2027)
9.3 Europe Liposomes Drug Delivery Sales by Type
9.4 Europe Liposomes Drug Delivery Sales by Application
10 Latin America
10.1 Latin America Liposomes Drug Delivery Market Size YoY Growth 2016-2027
10.2 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposomes Drug Delivery Sales by Country (2016-2027)
10.2.2 Latin America Liposomes Drug Delivery Revenue by Country (2016-2027)
10.3 Latin America Liposomes Drug Delivery Sales by Type
10.4 Latin America Liposomes Drug Delivery Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Liposomes Drug Delivery Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposomes Drug Delivery Sales by Country (2016-2027)
11.2.2 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2016-2027)
11.3 Middle East and Africa Liposomes Drug Delivery Sales by Type
11.4 Middle East and Africa Liposomes Drug Delivery Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Liposomes Drug Delivery Supply Chain Analysis
12.2 Liposomes Drug Delivery Key Raw Materials and Upstream Suppliers
12.3 Liposomes Drug Delivery Clients Analysis
12.4 Liposomes Drug Delivery Sales Channel and Sales Model Analysis
12.4.1 Liposomes Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Liposomes Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Liposomes Drug Delivery Distributors
13 Market Dynamics
13.1 Liposomes Drug Delivery Market Drivers
13.2 Liposomes Drug Delivery Market Opportunities
13.3 Liposomes Drug Delivery Market Challenges
13.4 Liposomes Drug Delivery Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Liposomes Drug Delivery Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposomes Drug Delivery Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Liposomes Drug Delivery Sales by Region (2016-2021) & (K Vials)
Table 9. Global Liposomes Drug Delivery Sales Forecast by Region (2022-2027) & (K Vials)
Table 10. Global Liposomes Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Liposomes Drug Delivery Sales by Manufacturer (2016-2021) & (K Vials)
Table 13. Global Liposomes Drug Delivery Sales Share by Manufacturer (2016-2021)
Table 14. Liposomes Drug Delivery Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Liposomes Drug Delivery Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Liposomes Drug Delivery Price (2016-2021) & (USD/Vial)
Table 17. Ranking of Global Top Liposomes Drug Delivery Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2020)
Table 20. Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Liposomes Drug Delivery Product Type
Table 22. Date of International Manufacturers Enter into Liposomes Drug Delivery Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Johnson & Johnson Corporation Information
Table 25. Johnson & Johnson Description and Business Overview
Table 26. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 27. Johnson & Johnson Liposomes Drug Delivery Product
Table 28. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 29. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 30. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Johnson & Johnson Recent Development
Table 33. Gilead Sciences Corporation Information
Table 34. Gilead Sciences Description and Business Overview
Table 35. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 36. Gilead Sciences Liposomes Drug Delivery Product
Table 37. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 38. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 39. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Gilead Sciences Recent Development
Table 42. Pacira Corporation Information
Table 43. Pacira Description and Business Overview
Table 44. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 45. Pacira Liposomes Drug Delivery Product
Table 46. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 47. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 48. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Pacira Recent Development
Table 51. Sun Pharmaceutical Corporation Information
Table 52. Sun Pharmaceutical Description and Business Overview
Table 53. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 54. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 55. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 56. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 57. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Sun Pharmaceutical Recent Development
Table 60. Luye Pharma Corporation Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 63. Luye Pharma Liposomes Drug Delivery Product
Table 64. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 65. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 66. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Luye Pharma Recent Development
Table 69. Sigma-Tau Group Corporation Information
Table 70. Sigma-Tau Group Description and Business Overview
Table 71. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 72. Sigma-Tau Group Liposomes Drug Delivery Product
Table 73. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 74. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 75. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 76. Sigma-Tau Group Recent Development
Table 77. Fudan-Zhangjiang Corporation Information
Table 78. Fudan-Zhangjiang Description and Business Overview
Table 79. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 80. Fudan-Zhangjiang Liposomes Drug Delivery Product
Table 81. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 82. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 83. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 84. Fudan-Zhangjiang Recent Development
Table 85. Teva Pharmaceutical Corporation Information
Table 86. Teva Pharmaceutical Description and Business Overview
Table 87. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 88. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 89. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 90. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 91. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 92. Teva Pharmaceutical Recent Development
Table 93. CSPC Corporation Information
Table 94. CSPC Description and Business Overview
Table 95. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 96. CSPC Liposomes Drug Delivery Product
Table 97. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 98. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 99. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 100. CSPC Recent Development
Table 101. Novartis Corporation Information
Table 102. Novartis Description and Business Overview
Table 103. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 104. Novartis Liposomes Drug Delivery Product
Table 105. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 106. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 107. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Novartis Recent Development
Table 109. Kingond Pharm Corporation Information
Table 110. Kingond Pharm Description and Business Overview
Table 111. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 112. Kingond Pharm Liposomes Drug Delivery Product
Table 113. Kingond Pharm Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 114. Kingond Pharm Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 115. Kingond Pharm Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Kingond Pharm Recent Development
Table 117. Spectrum Pharmaceuticals Corporation Information
Table 118. Spectrum Pharmaceuticals Description and Business Overview
Table 119. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 120. Spectrum Pharmaceuticals Liposomes Drug Delivery Product
Table 121. Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 122. Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 123. Spectrum Pharmaceuticals Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 124. Spectrum Pharmaceuticals Recent Development
Table 125. Shanghai New Asia Corporation Information
Table 126. Shanghai New Asia Description and Business Overview
Table 127. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 128. Shanghai New Asia Liposomes Drug Delivery Product
Table 129. Shanghai New Asia Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 130. Shanghai New Asia Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 131. Shanghai New Asia Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 132. Shanghai New Asia Recent Development
Table 133. Global Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 134. Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027) & (K Vials)
Table 135. Global Liposomes Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 136. Global Liposomes Drug Delivery Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 137. Global Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 138. Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027) & (K Vials)
Table 139. Global Liposomes Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 140. Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 141. North America Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 142. North America Liposomes Drug Delivery Sales by Country (2022-2027) & (K Vials)
Table 143. North America Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 144. North America Liposomes Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 145. North America Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 146. North America Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 147. Asia-Pacific Liposomes Drug Delivery Sales by Region (2016-2021) & (K Vials)
Table 148. Asia-Pacific Liposomes Drug Delivery Sales by Region (2022-2027) & (K Vials)
Table 149. Asia-Pacific Liposomes Drug Delivery Revenue by Region (2016-2027) & (US$ Million)
Table 150. Asia-Pacific Liposomes Drug Delivery Revenue by Region (2022-2027) & (US$ Million)
Table 151. Asia-Pacific Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 152. Asia-Pacific Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 153. Europe Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 154. Europe Liposomes Drug Delivery Sales by Country (2022-2027) & (K Vials)
Table 155. Europe Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 156. Europe Liposomes Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 157. Europe Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 158. Europe Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 159. Latin America Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 160. Latin America Liposomes Drug Delivery Sales by Country (2022-2027) & (K Vials)
Table 161. Latin America Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 162. Latin America Liposomes Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 163. Latin America Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 164. Latin America Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 165. Middle East and Africa Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 166. Middle East and Africa Liposomes Drug Delivery Sales by Country (2022-2027) & (K Vials)
Table 167. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 168. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 169. Middle East and Africa Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vials)
Table 170. Middle East and Africa Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vials)
Table 171. Liposomes Drug Delivery Key Raw Materials, Industry Status and Trend
Table 172. Liposomes Drug Delivery Key Raw Materials and Upstream Suppliers
Table 173. Liposomes Drug Delivery Clients Status and Trend
Table 174. Liposomes Drug Delivery Typical Clients
Table 175. Liposomes Drug Delivery Distributors
Table 176. Key Drivers: Impact Analysis (2022-2027)
Table 177. Liposomes Drug Delivery Market Drivers
Table 178. Liposomes Drug Delivery Market Opportunities
Table 179. Liposomes Drug Delivery Market Challenges
Table 180. Liposomes Drug Delivery Market Restraints
Table 181. Liposomes Drug Delivery Porter's Five Forces Analysis
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Drug Delivery Product Picture
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposomes Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 8. Fungal Infection Therapy Examples
Figure 9. Cancer & Tumor Therapy Examples
Figure 10. Others Examples
Figure 11. Liposomes Drug De

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs